Literature DB >> 32382948

Therapeutic Strategies to Treat or Prevent Off Episodes in Adults with Parkinson's Disease.

Nirosen Vijiaratnam1,2, Thomas Foltynie3,4.   

Abstract

Parkinson's disease is a chronic, neurodegenerative disease, which manifests with a mixture of motor, cognitive and behavioural symptoms. Levodopa is the most effective antiparkinsonian treatment to date, although chronic use engenders a mixture of complications in a substantial proportion of patients. Amongst these is the occurrence of episodes of worsening symptoms-'off' phenomena. These episodes can manifest with either motor or non-motor symptoms or a combination of these features and have been found to have profound impacts on patients' quality of life. Although preventative measures are poorly evidenced, avoiding excessive total daily levodopa intake in selected populations that are deemed to be of a higher risk for developing these episodes warrants further exploration. Methods to improve levodopa bioavailability and delivery to the brain are currently available and are of value in addressing these episodes once they have become established. These include modifications to levodopa formulations as well as the use of complimentary agents that improve levodopa bioavailability. The deployment of device-assisted approaches is a further dimension that can be considered in addressing these debilitating episodes. This review summarises the clinical manifestations of 'off' phenomena and the current approaches to treat them. Although we briefly discuss clinical advances on the horizon, the predominant focus is on existing, established treatments.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32382948     DOI: 10.1007/s40265-020-01310-2

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  11 in total

Review 1.  Revisiting the assessment of tremor: clinical review.

Authors:  Nirosen Vijiaratnam; Thomas Wirth; Huw R Morris
Journal:  Br J Gen Pract       Date:  2020-11-26       Impact factor: 5.386

2.  Opicapone: A Review in Parkinson's Disease.

Authors:  Lesley J Scott
Journal:  CNS Drugs       Date:  2021-01-11       Impact factor: 5.749

Review 3.  Closing the loop for patients with Parkinson disease: where are we?

Authors:  Hazhir Teymourian; Farshad Tehrani; Katherine Longardner; Kuldeep Mahato; Tatiana Podhajny; Jong-Min Moon; Yugender Goud Kotagiri; Juliane R Sempionatto; Irene Litvan; Joseph Wang
Journal:  Nat Rev Neurol       Date:  2022-06-09       Impact factor: 44.711

4.  Scanning Imaging Study of Patients with Parkinson's Disease Lower Urinary Tract Dysfunction Based on Linear Equation.

Authors:  Yong Liu; Jiasheng Han; Xuguang Guo; Lei Fang; Ting Liu
Journal:  Scanning       Date:  2022-05-27       Impact factor: 1.750

Review 5.  The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and Suitability.

Authors:  Christine Girges; Nirosen Vijiaratnam; Dilan Athauda; Grace Auld; Sonia Gandhi; Thomas Foltynie
Journal:  Drugs Aging       Date:  2021-03-19       Impact factor: 3.923

6.  Patient Preferences for Treating "OFF" Episodes in Parkinson's Disease: A Discrete Choice Experiment.

Authors:  Andrew Thach; Jessie Sutphin; Joshua Coulter; Colton Leach; Eric Pappert; Carol Mansfield
Journal:  Patient Prefer Adherence       Date:  2021-06-01       Impact factor: 2.711

Review 7.  Istradefylline to Treat Patients with Parkinson's Disease Experiencing "Off" Episodes: A Comprehensive Review.

Authors:  Amnon A Berger; Ariel Winnick; Alexandra Welschmeyer; Alicia Kaneb; Kevin Berardino; Elyse M Cornett; Alan D Kaye; Omar Viswanath; Ivan Urits
Journal:  Neurol Int       Date:  2020-12-08

8.  Istradefylline Versus Opicapone for "Off" Episodes in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Alok Singh; Dhyuti Gupta; Suryaprakash Dhaneria; Pranav G Sheth
Journal:  Ann Neurosci       Date:  2021-10-05

Review 9.  Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease.

Authors:  Daniel Garbin Di Luca; Nikolai Gil D Reyes; Susan H Fox
Journal:  Drugs       Date:  2022-07-16       Impact factor: 11.431

Review 10.  Zonisamide's Efficacy and Safety on Parkinson's Disease and Dementia with Lewy Bodies: A Meta-Analysis and Systematic Review.

Authors:  Linghui Kong; Jiaqiu Xi; Zhenyuan Jiang; Xiaowen Yu; Hailiang Liu; Zhonglin Wang
Journal:  Biomed Res Int       Date:  2022-09-12       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.